Fetal erythropoiesis and the diagnosis and treatment of hemoglobin disorders in the fetus and child

Seminars in Perinatology

Volumn 21, Issue 1, 1997, Pages 63-69

  Olivieri, N F ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARYLBUTYRIC ACID DERIVATIVE; BETA GLOBIN; HYDROXYUREA;

ALPHA THALASSEMIA; BETA THALASSEMIA; CHILD DEATH; CONFERENCE PAPER; DISEASE SEVERITY; ERYTHROPOIESIS; FETUS; FETUS DISEASE; GENE CLUSTER; HEMOGLOBIN DETERMINATION; HEMOGLOBIN SYNTHESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; NEWBORN; PRIORITY JOURNAL;

EID: 0030954617     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-0005(97)80021-3     Document Type: Conference Paper

References (53)

1. Weatherall DJ Clegg JB The Thalassemia Syndromes 1981 Blackwell Scientific Publications Oxford UK
2. Weatherall DJ Clegg JB Boon WH The hemoglobin constitution of infants with the haemoglobin Bart's hydrops fetalis syndrome Br J Haematol 18 1970 357 367
3. Wood WG Increased HbF in adult life Clin Haematol 6 1993 177 213
4. Beaudry MA Ferguson DJ Pearse K Survival of a hydropic infant with homozygous α-thalassemia-1 J Pediatr 108 1986 713 716
5. Bianchi DW Beyer EC Stark AR Normal long-term survival with α-thalassemia J Pediatr 108 1986 716 718
6. Lam T-K Chan V Fok T-F Long-term survival of a baby with homozygous alpha-thalassemia-1 Acta Haematol 88 1992 198 200
7. (abstr) Abuelo DN Forman E Limb reduction defects in an infant with homozygous alpha thalassemia Presented at the Second Joint Clinical Genetics Meeting 1995
8. Carr S Rubin L Dixon D Intrauterine therapy for homozygous a-thalassemia Obstet Gynecol 85 1995 876 879
9. Olivieri NF Nathan DG MacMillan JH Survival in medically treated patients with homozygous β thalassemia N Engl J Med 331 1994 574 578
10. Brittenham GM Griffith PM Nienhuis AW Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major N Engl J Med 331 1994 567 573
11. Lucarelli G Galimberti M Polchi P Marrow transplantation in patients with thalassemia responsive to iron chelation therapy N Engl J Med 329 1993 840 844
12. Machin GA Popkin JS Styles S Termination of pregnancy during the third trimester N Engl J Med 311 1984 264 265
13. Anderson HM Ranney HM Southeast Asian immigrants: The new thalassemias in America Semin Hematol 27 1990 239 246
14. Noguchi CT Rodgers GP Serjeant G Levels of fetal hemoglobin necessary for the treatment of sickle cell disease N Engl J Med 318 1988 96 99
15. Goldberg MA Husson MA Bunn HF Participation of hemoglobins A and F in polymerization of sickle hemoglobin J Biol Chem 252 1977 3414 3421
16. Perrine RP Brown MJ Clegg JB Benign sickle-cell anemia Lancet 2 1972 1163 1167
17. Wood WG Pembrey ME Serjeant GR Hb F synthesis in sickle cell anemia: A comparison of Saudi Arab cases with those of African origin Br J Haematol 45 1980 431 445
18. Brittenham GM Schechter AN Noguchi CT Hemoglobin S polymerization: primary determinant of the hemolytic and clinical severity of the sickling syndromes Blood 65 1985 183 189
19. Cao A Galanello R Rosatelli MC Genotype-phenotype correlations in -thalassemias Blood Rev 8 1994 1 12
20. Serjeant GR Sickle Cell Disease 1992 Oxford University Press Oxford, UK 369 378
21. Pembrey ME Wood WG Weatherall DJ Fetal hemoglobin production and the sickle gene in the Oases of eastern Saudi Arabia Br J Haematol 40 1978 415 429
22. Platt OS Thorington BD Brambilla DJ Pain in sickle cell disease N Engl J Med 325 1991 11 16
23. Wood WG Weatherall DJ Developmental genetics of the human hemoglobins Biochem J 215 1983 1 10
24. Olivieri NF Reactivation of fetal hemoglobin in patients with thalassemia Semin Hematol 33 1996 24 42
25. Charache S Fetal hemoglobin, sickling, and sickle cell disease Adv Pediatr 37 1990 1 31
26. Leikin SL Gallagher D Kinney TR Mortality in children and adolescents with sickle cell disease Pediatrics 84 1989 500 508
27. Platt OS Brambilla DJ Rosse WF Mortality in sickle cell disease: Life expectancy and risk factors for early death N Engl J Med 330 1994 1639 1644
28. Charache S Terrin ML Moore RD Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia N Engl J Med 332 1995 1317 1322
29. (abstr) Ohene-Frempong K Horiuchi K Bulgarelli W Hydroxyurea increases HbF production in children with sickle cell disease Blood 82 1993 472a
30. (abstr) de Montalembert Belloy M Bernaudin F Clinical and hematological response of sickle cell children to treatment with hydroxyurea Blood 84 1994 219a
31. (abstr) Labotka RJ Misiewicz VM Robinson E Hydroxyurea therapy in severely affected children with sickle cell disease Pediatr Res 35 1994 163a
32. Scott JP Hillery CA Brown ER Hydroxyurea therapy in children severely affected with sickle cell disease J Pediatr 128 1996 820 828
33. (abstr) Olivieri NF Basran R Nisbet-Brown E Hydroxyurea in children with sickle cell disease Blood 88 1996 621a
34. Pearson HA Spenser RP Cornelius EA Functional asplenia in sickle cell anemia N Engl J Med 281 1969 923
35. (abstr) Lane PA O'Connell JL Kinney TR Hydroxyurea increases red cell pit counts in children and adolescents with sickle cell anemia: implications for assessment of splenic function Blood 86 1995 140a
36. (abstr) Steinberg MH Lu Z-H Barton F Fetal hemoglobin in sickle cell anemia: determinants of response to hydroxyurea Blood 86 1995 418a
37. (abstr) McDonagh KT Orringer EP Dover GJ Hydroxyurea improves erythropoiesis in a patient with homozygous beta thalassemia Clin Res 38 1990 346A
38. Nienhuis AW Ley TJ Humphries RK Pharmacological manipulation of fetal hemoglobin synthesis in patients with severe beta thalassemia Ann NY Acad Sci 445 1985 198 211
39. Loukopoulos D Voskaridou E Stamoulakatou A Clinical trials with hydroxyurea and recombinant human erythropoietin, in Stamatoyannopoulos G Nienhuis AW Hemoglobin Switching 1995 Alan R. Liss New York, NY 365 372
40. Fucharoen S Siritanaratkul N Winichagoon P Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in β-thalassemia/hemoglobin E disease Blood 87 1996 887 892
41. Perrine SP Ginder GD Faller DV A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders N Engl J Med 328 1993 81 86
42. Sher GD Ginder G Little JA Extended therapy with arginine butyrate in patients with thalassemia and sickle cell disease N Engl J Med 332 1995 106 110
43. Collins AF Pearson HA Giardina P Oral sodium phenylbutyrate therapy in homozygous beta thalassemia Blood 85 1995 43 49
44. Rachmilewitz EA Goldfarb A Dover G Administration of erythropoietin to patients with β-thalassemia intermedia: A preliminary trial Blood 78 1991 1145 1147
45. Olivieri NF Freedman M Perrine S Trial of recombinant human erythropoietin in thalassemia intermedia Blood 80 1992 3258 3260
46. Rachmilewitz EA Aker M Perry D Sustained increase in haemoglobin and RBC following long-term administration of recombinant human erythropoietin to patients with homozygous beta thalassemia Br J Haematol 90 1995 341 345
47. Lowrey CH Nienhuis AW Brief report: Treatment with azacytidine of patients with end-stage- β -thalassemia N Engl J Med 329 1993 845 849
48. + thalassemia N Engl J Med 307 1982 1469 1475
49. (abstr) Olivieri NF Rees DC Ginder GD First report of long-term elimination of red cell transfusions in thalassemia major through augmentation of fetal hemoglobin with sodium phenylbutyrate and hydroxyurea Blood 88 1996 310a
50. Huebers HA Beguin Y Pootrakul P Intact transferrin receptors in human plasma and their relation to erythropoiesis Blood 75 1990 102 107
51. Beguin Y The soluble transferrin receptor: biological aspects and clinical usefulness as quantitative measure of erythropoiesis Haematologica (Pavia) 77 1992 1 10
52. Weatherall DJ McIntyre PA Developmental and acquired variations in erythrocyte carbonic anhydrase isozymes Br J Haematol 13 1967 106 114
53. Rees DC Thein SW Dover GJ Profound increases in fetal hemoglobin during hydroxyurea and butyrate therapy are not associated with reversion to fetal erythropoiesis Blood 88 1996 311a